Flagship reveals machine learning-based protein drug discovery startup Generate Biomedicines

Flagship reveals machine learning-based protein drug discovery startup Generate Biomedicines

Source: 
MedCity News
snippet: 

The company said it had used its machine learning platform to generate multiple antibodies and peptides against the Covid-19 virus in less than 17 days and could potentially create hitherto "impossible" protein-based therapeutics.